Nuclear Antigen antibody
Quick Overview for Nuclear Antigen antibody (ABIN3025764)
Target
See all Nuclear Antigen (IPO-38) AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Purpose
- IPO-38 Antibody (Proliferation Marker) (azide and preservative free)
-
Purification
- PEG precipitation
-
Immunogen
- Spleen cells from a patient with hairy cell leukemia were used as the immunogen for the IPO-38 antibody.
-
Isotype
- IgM, kappa
-
-
-
-
Application Notes
-
Optimal dilution of the IPO-38 antibody should be determined by the researcher.
1. Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM Citrate buffer, pH 6.0, for 10-20 min followed by cooling at RT for 20 min.
2. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min. -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 mg/mL
-
Buffer
- 1 mg/mL in 1X PBS, BSA free, sodium azide free
-
Preservative
- Azide free
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store the IPO-38 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
-
-
- Nuclear Antigen (IPO-38)
-
Alternative Name
- IPO-38
-
Background
- Recognizes a protein of 14-16 kDa, which is a novel nuclear antigen of proliferating cells. IPO38 antigen is present in the nuclei of proliferating cells such as Hodgkin s disease and non-Hodgkin s lymphomas, different forms of leukemias, breast and colorectal carcinomas, and PHA-stimulated lymphocytes. It is not expressed in the cells of non-stimulated lymphocytes and granulocytes. IPO38 may be a useful marker of cell proliferation during monitoring of tumor progression.
Target
-